“Bullish on Biocon, recommending a buy at CMP ₹426.8 with a target of ₹470 and a stop-loss at ₹405. The stock has confirmed a breakout from a prolonged consolidation phase above the ₹400 mark, supported by improving price momentum and forming a strong pivot for accumulation.”

Ajit Mishra’s track record: 7 graded calls · 95% CI 8–64%